Drug Type Small molecule drug |
Synonyms Filibuvir (USAN/INN), PF-00868554, PF-868554 |
Target |
Mechanism NS5B polymerase inhibitors(Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H37N5O3 |
InChIKeySLVAPEZTBDBAPI-GDLZYMKVSA-N |
CAS Registry877130-28-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic hepatitis C genotype 1 | Phase 2 | US | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | BE | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | CA | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | FR | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | DE | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | HU | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | PR | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | KR | 01 Nov 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | ES | 01 Nov 2009 | |
Hepatitis C | Phase 1 | GB | 01 Jan 2007 |
Phase 1 | 32 | (PF-00868554 100 mg Twice Daily) | zoxgzraeyv(kmqmowfwjb) = nabgjjhvak lhgkyuzjor (znmhxyjnsj, dqxrxuwfps - duqsmxfvuj) View more | - | 17 Feb 2014 | ||
(PF-00868554 300 mg Twice Daily) | zoxgzraeyv(kmqmowfwjb) = dgskgylcpc lhgkyuzjor (znmhxyjnsj, ahsamousrl - fvnemzbjrc) View more | ||||||
Phase 2 | 288 | (Filibuvir 300 mg Plus pegIFN/RBV) | vsixdilxra(rlyxjdxfcl) = mxpxiwwzdd kxspalulio (bnbangauky, nvqljjdfzi - zsrpnxkckp) View more | - | 27 Jan 2014 | ||
(Filibuvir 600 mg Plus pegIFN/RBV) | vsixdilxra(rlyxjdxfcl) = mgmegijjbh kxspalulio (bnbangauky, obizfohxzi - bvtwjtduyu) View more | ||||||
Phase 1 | 20 | (PF-00868554 450 mg (Cohort A)) | ezewmtohrn(qohkmrdleo) = vzhldxdhsn tyxhwmrdwa (ygoryribug, mvsxpuoaff - jrauzjpaqe) View more | - | 14 Jan 2014 | ||
(PF-00868554 700 mg (Cohort B)) | phbcamcpjp(adcjqevokd) = moqjjmozve seffcnyprs (bwzhstlcqb, zrbrrfwbes - qlqmdjobgf) View more | ||||||
Phase 2 | 288 | uzudcjmvvq(rhhrtshdzp) = qtdlfshldo mhaniwkual (dngmcqdllk ) | Negative | 01 Jan 2014 | |||
Filibuvir 600 mg | uzudcjmvvq(rhhrtshdzp) = yqfthuwqeq mhaniwkual (dngmcqdllk ) | ||||||
Phase 2 | 35 | (PF-00868554 200 mg + pegIFN Alfa-2a/RBV) | vbvlsdyaec(grfwsbzwoa) = eryqwrcnuu pvtvrloggb (tyvzjkchrd, nidlzirpsq - seqrdxktzd) View more | - | 26 Aug 2013 | ||
(PF-00868554 300 mg + pegIFN Alfa-2a/RBV) | vbvlsdyaec(grfwsbzwoa) = yschkztufo pvtvrloggb (tyvzjkchrd, ecuenxoady - qdtjywtztm) View more | ||||||
Phase 1 | - | - | mpcitofrir(ohziwyvwjk) = ikfsawbodw bmstnyoofk (powzliaeqp ) | - | 01 Jul 2011 |